Leukemia susceptibility disorders
Underlying biology . | Disease/syndrome . | Gene(s) . | Inheritance pattern . | Leukemia subtype . | Cytopenias and nonmalignant hematologic features . | Nongenetic diagnostic testing . | Other manifestations . | |
---|---|---|---|---|---|---|---|---|
DNA repair | Fanconi anemia | FANCA through FANCW (n = 22)* | AR (1 XLR, 1 AD) | AML | Single or pancytopenia, elevated HbF, macrocytosis | Increased chromosome breakage | Short stature, radial ray anomalies, microcephaly, café au lait spots* | |
Nijmegen breakage syndrome | NBN | AR | ALL | Immunodeficiency | Ionizing radiation sensitivity of lymphocytes | Microcephaly, microgenia, bird-like facies | ||
Ataxia telangiectasia | ATM | AR | ALL | Immunodeficiency | Cerebellar ataxia, conjunctival telangiectasias choreoathetosis, oculomotor apraxia | |||
Bloom syndrome | BLM (RECQL3) | AR | ALL or AML | Growth deficiency, sun sensitivity, reflux, insulin resistance | ||||
CMMRDS (Turcot) | MSH1, MSH2, MSH6, PMS2, EPCAM | AR | ALL or AML | Heterozygous form leads to Lynch syndrome | ||||
Ribosome biogenesis | Shwachman Diamond syndrome | SDBS, DNAJC21, EFL1† | AR | AML | Neutropenia | Low serum isoamylase and trypsinogen | Exocrine pancreatic insufficiency, neurodevelopmental and skeletal abnormalities* | |
Diamond Blackfan anemia | RPLs, RPSs, TSR2, GATA1 (n = 20)* | AD | AML | Erythroid hypoplasia, elevated HbF | Elevated erythroid ADA | Short stature, craniofacial anomalies, bifid thumbs* | ||
Telomere biology | Dyskeratosis congenita | Telomerase and shelterin components (n = 14)* | AR, AD, XLR | AML | Single or pancytopenia, elevated HbF, macrocytosis | Very short telomeres | Skin pigmentation, nail dysplasia, oral leukoplakia, pulmonary fibrosis* | |
Hematopoietic transcription factors | Familial platelet disorder | RUNX1 | AD | AML | Thrombocytopenia | |||
GATA2 deficiency | GATA2 | AD | AML | Monocytopenia; low NK, dendritic, and/or B cells | Lymphedema, warts, nontuberculous mycobacterial infections, alveolar proteinosis | |||
Familial AML | CEBPA | AD | AML | |||||
Thrombocytopenia, type 5 | ETV6 | AD | ALL, rarely AML | Thrombocytopenia, macrocytosis | ||||
Susceptibility to ALL-3 | PAX5 | AD | ALL | |||||
Tumor suppressors | Li-Fraumeni syndrome | TP53 | AD | AML or ALL | Clinically based on personal and family history | Other cancers, including brain tumors, sarcomas, breast and adrenocortical carcinomas | ||
Neurofibromatosis type 1 | NF1 | AD | JMML | Clinically based on personal and family history | Café au lait spots, Lisch nodules, neurofibromas | |||
Noonan syndrome | PTPN11 | AD | JMML | Bleeding diathesis | Short stature, facial dysmorphism, congenital heart defects | |||
Neutrophil development | Severe congenital neutropenia | ELA2, GFI1, G6PC3, GCSFR, HAX1 | AD, AR | AML | Neutropenia | Severe bacterial infections | ||
Other cell processes | DDX41-related myeloid neoplasia | DDX41 | AD | AML | Thrombocytopenia | |||
MIRAGE | SAMD9 | AD | AML | Thrombocytopenia, anemia | Infections, growth restriction, adrenal hypoplasia, genital malformations, enteropathy | |||
Ataxia-pancytopenia syndrome | SAMD9L | AD | AML | Thrombocytopenia, anemia | Cerebellar ataxia | |||
Thrombocytopenia, type 2 | ANKRD26 | AD | AML | Thrombocytopenia, hypogranular platelets | ||||
Familial ALL with germline SH2B3 mutation | SH2B3 | AR | ALL | |||||
Chromosomal aneuploidies | Down syndrome | Trisomy 21 | ALL or AMKL | Transient myeloproliferative disorder | Congenital heart defects, intellectual disability, characteristic facies, gastrointestinal tract malformations, hearing loss | |||
Myelodysplasia and leukemia syndrome with monosomy 7 | Monosomy 7 | AML | Macrocytosis |
Underlying biology . | Disease/syndrome . | Gene(s) . | Inheritance pattern . | Leukemia subtype . | Cytopenias and nonmalignant hematologic features . | Nongenetic diagnostic testing . | Other manifestations . | |
---|---|---|---|---|---|---|---|---|
DNA repair | Fanconi anemia | FANCA through FANCW (n = 22)* | AR (1 XLR, 1 AD) | AML | Single or pancytopenia, elevated HbF, macrocytosis | Increased chromosome breakage | Short stature, radial ray anomalies, microcephaly, café au lait spots* | |
Nijmegen breakage syndrome | NBN | AR | ALL | Immunodeficiency | Ionizing radiation sensitivity of lymphocytes | Microcephaly, microgenia, bird-like facies | ||
Ataxia telangiectasia | ATM | AR | ALL | Immunodeficiency | Cerebellar ataxia, conjunctival telangiectasias choreoathetosis, oculomotor apraxia | |||
Bloom syndrome | BLM (RECQL3) | AR | ALL or AML | Growth deficiency, sun sensitivity, reflux, insulin resistance | ||||
CMMRDS (Turcot) | MSH1, MSH2, MSH6, PMS2, EPCAM | AR | ALL or AML | Heterozygous form leads to Lynch syndrome | ||||
Ribosome biogenesis | Shwachman Diamond syndrome | SDBS, DNAJC21, EFL1† | AR | AML | Neutropenia | Low serum isoamylase and trypsinogen | Exocrine pancreatic insufficiency, neurodevelopmental and skeletal abnormalities* | |
Diamond Blackfan anemia | RPLs, RPSs, TSR2, GATA1 (n = 20)* | AD | AML | Erythroid hypoplasia, elevated HbF | Elevated erythroid ADA | Short stature, craniofacial anomalies, bifid thumbs* | ||
Telomere biology | Dyskeratosis congenita | Telomerase and shelterin components (n = 14)* | AR, AD, XLR | AML | Single or pancytopenia, elevated HbF, macrocytosis | Very short telomeres | Skin pigmentation, nail dysplasia, oral leukoplakia, pulmonary fibrosis* | |
Hematopoietic transcription factors | Familial platelet disorder | RUNX1 | AD | AML | Thrombocytopenia | |||
GATA2 deficiency | GATA2 | AD | AML | Monocytopenia; low NK, dendritic, and/or B cells | Lymphedema, warts, nontuberculous mycobacterial infections, alveolar proteinosis | |||
Familial AML | CEBPA | AD | AML | |||||
Thrombocytopenia, type 5 | ETV6 | AD | ALL, rarely AML | Thrombocytopenia, macrocytosis | ||||
Susceptibility to ALL-3 | PAX5 | AD | ALL | |||||
Tumor suppressors | Li-Fraumeni syndrome | TP53 | AD | AML or ALL | Clinically based on personal and family history | Other cancers, including brain tumors, sarcomas, breast and adrenocortical carcinomas | ||
Neurofibromatosis type 1 | NF1 | AD | JMML | Clinically based on personal and family history | Café au lait spots, Lisch nodules, neurofibromas | |||
Noonan syndrome | PTPN11 | AD | JMML | Bleeding diathesis | Short stature, facial dysmorphism, congenital heart defects | |||
Neutrophil development | Severe congenital neutropenia | ELA2, GFI1, G6PC3, GCSFR, HAX1 | AD, AR | AML | Neutropenia | Severe bacterial infections | ||
Other cell processes | DDX41-related myeloid neoplasia | DDX41 | AD | AML | Thrombocytopenia | |||
MIRAGE | SAMD9 | AD | AML | Thrombocytopenia, anemia | Infections, growth restriction, adrenal hypoplasia, genital malformations, enteropathy | |||
Ataxia-pancytopenia syndrome | SAMD9L | AD | AML | Thrombocytopenia, anemia | Cerebellar ataxia | |||
Thrombocytopenia, type 2 | ANKRD26 | AD | AML | Thrombocytopenia, hypogranular platelets | ||||
Familial ALL with germline SH2B3 mutation | SH2B3 | AR | ALL | |||||
Chromosomal aneuploidies | Down syndrome | Trisomy 21 | ALL or AMKL | Transient myeloproliferative disorder | Congenital heart defects, intellectual disability, characteristic facies, gastrointestinal tract malformations, hearing loss | |||
Myelodysplasia and leukemia syndrome with monosomy 7 | Monosomy 7 | AML | Macrocytosis |
AD, autosomal dominant; ADA, adenosine deaminase; ALL, acute lymphoblastic leukemia; AMKL, acute megakaryoblastic leukemia; AML, acute myeloid leukemia; AR, autosomal recessive; CMMRDS, congenital mismatch repair deficiency syndrome; HbF, fetal hemoglobin; JMML, juvenile myelomonocytic leukemia; MIRAGE, myelodysplasia, infection, restriction of growth, adrenal hypoplasia, genital phenotypes, and enteropathy; NK, natural killer; XLR, X-linked recessive.
Additional detail can be seen in Alter (in this book48 ).
Leukemia has not been reported in patients with Shwachman Diamond syndrome attributable to mutations in EFL1.